Marguerite Stas

2.4k total citations
50 papers, 1.6k citations indexed

About

Marguerite Stas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marguerite Stas has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Marguerite Stas's work include Central Venous Catheters and Hemodialysis (11 papers), Cutaneous Melanoma Detection and Management (9 papers) and Sarcoma Diagnosis and Treatment (9 papers). Marguerite Stas is often cited by papers focused on Central Venous Catheters and Hemodialysis (11 papers), Cutaneous Melanoma Detection and Management (9 papers) and Sarcoma Diagnosis and Treatment (9 papers). Marguerite Stas collaborates with scholars based in Belgium, United States and Netherlands. Marguerite Stas's co-authors include Joost J. van den Oord, Chris De Wolf‐Peeters, Anouk Demunter, H. Degreef, Véronique Winnepenninckx, Godelieve Goossens, Stefan Michiels, Joost van den Oord, Vladimir Lazar and Alan Spatz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marguerite Stas

46 papers receiving 1.6k citations

Peers

Countries citing papers authored by Marguerite Stas

Since Specialization

Citations

This map shows the geographic impact of Marguerite Stas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marguerite Stas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marguerite Stas more than expected).

Fields of papers citing papers by Marguerite Stas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marguerite Stas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marguerite Stas. The network helps show where Marguerite Stas may publish in the future.

Co-authorship network of co-authors of Marguerite Stas

This figure shows the co-authorship network connecting the top 25 collaborators of Marguerite Stas. A scholar is included among the top collaborators of Marguerite Stas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marguerite Stas. Marguerite Stas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population 2022 ·Acta Dermato Venereologica ·(unknown), Sofie Van Kelst, (unknown), (unknown), Veerle Boecxstaens, Marguerite Stas, Dirk Vanderschueren, Ipek Guler, Kris Bogaerts, Katleen Vandenberghe, Oliver Bechter, Jaak Billen, Arjen Nikkels, (unknown), Gabriella Emri, Diether Lambrechts, Marjan Garmyn	6
2	Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas 2021 ·International Journal of Molecular Sciences ·(unknown), Asier Antoranz, Anna Szumera‐Ciećkiewicz, Paweł Teterycz, Piotr Rutkowski, Robert V. Rawson, Richard A. Scolyer, John F. Thompson, Julia Newton‐Bishop, Marguerite Stas, Veerle Boecxstaens, Oliver Bechter, Jurgen Vercauteren, Marjan Garmyn, Joost van den Oord, Francesca M. Bosisio	3
3	Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing 2019 ·Molecular Cancer Therapeutics ·Jasmien Cornillie, Agnieszka Woźniak, Haifu Li, (unknown), Bram Boeckx, Yemarshet K. Gebreyohannes, Jasmien Wellens, Ulla Vanleeuw, Daphne Hompes, Marguerite Stas, Friedl Sinnaeve, Hazem Wafa, Diether Lambrechts, Maria Dêbiec‐Rychter, Raf Sciot, Patrick Schöffski	27
4	SecurAstaP trial: securement with SecurAcath versus StatLock for peripherally inserted central catheters, a randomised open trial 2018 ·BMJ Open ·Godelieve Goossens, (unknown), (unknown), (unknown), Steffen Fieuws, Philip Moons, Marguerite Stas, Geert Maleux	19
5	Successful forearm prosthesis fitting in a patient with epidermolysis bullosa dystrophica 2017 ·Prosthetics and Orthotics International ·(unknown), Marie‐Anne Morren, Marguerite Stas, Friedl Sinnaeve, (unknown), Carlotte Kiekens	1
6	Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin 2015 ·Cancer Research ·Aleksandra M. Dudek-Perić, Gabriela B. Ferreira, Angelika Muchowicz, Jasper Wouters, Nicole Prada, Shaun Martin, Santeri Kiviluoto, Magdalena Winiarska, Louis Boon, Chantal Mathieu, Joost van den Oord, Marguerite Stas, Marie‐Lise Gougeon, Jakub Gołąb, Abhishek D. Garg, Patrizia Agostinis	84
7	Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients 2015 ·Drugs & Aging ·Aljosja Rogiers, Joost J. van den Oord, Marjan Garmyn, Marguerite Stas, Cindy Kenis, Hans Wildiers, Jean‐Christophe Marine, Pascal Wolter	12
8	Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models 2014 ·Translational Oncology ·Haifu Li, Agnieszka Woźniak, Raf Sciot, Jasmien Cornillie, Jasmien Wellens, Thomas Van Looy, Ulla Vanleeuw, Marguerite Stas, Daphne Hompes, Maria Dêbiec‐Rychter, Patrick Schöffski	36
9	A novel hypoxia-associated subset of FN1highMITFlow melanoma cells: identification, characterization, and prognostic value 2014 ·Modern Pathology ·Jasper Wouters, Marguerite Stas, Olivier Govaere, (unknown), Aleksandra M. Dudek, Hugo Vankelecom, Lauren E. Haydu, John F. Thompson, Richard A. Scolyer, Joost J. van den Oord	14
10	Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma 2013 ·Pigment Cell & Melanoma Research ·(unknown), Marjon A. Smit, Joost J. van den Oord, Jelle J. Goeman, Els M.E. Verdegaal, Sjoerd H. van der Burg, Marguerite Stas, Samuel J. Beck, Nelleke A. Gruis, Cornelis P. Tensen, Rein Willemze, Daniel S. Peeper, Remco van Doorn	49
11	Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases 2012 ·Cancer Research ·Arcadi Cipponi, Marjorie Mercier, Teofila Seremet, Jean‐François Baurain, Ivan Théate, Joost van den Oord, Marguerite Stas, Thierry Boon, Pierre G. Coulie, Nicolas van Baren	204
12	Administration of 24-h Intravenous Infusions of Trabectedin in Ambulatory Patients with Mesenchymal Tumors via Disposable Elastomeric Pumps: An Effective and Patient-Friendly Palliative Treatment Option 2012 ·Onkologie ·Patrick Schöffski, Linda Cerbone, Pascal Wolter, Ivo De Wever, Ignace Samson, Herlinde Dumez, Paul M. Clément, Hans Wildiers, Marguerite Stas	14
13	Gene expression changes in melanoma metastases in response to high‐dose chemotherapy during isolated limb perfusion 2012 ·Pigment Cell & Melanoma Research ·Jasper Wouters, Marguerite Stas, Olivier Govaere, Kathleen Van den Eynde, Hugo Vankelecom, Joost J. van den Oord	12
14	Prospective Clinical Evaluation of the Polyperf® Safe, a Safety Huber Needle, in Cancer Patients 2010 ·The Journal of Vascular Access ·Godelieve Goossens, Philip Moons, (unknown), Marguerite Stas	3
15	A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion 2007 ·Journal of Thrombosis and Thrombolysis ·Peter Verhamme, Godelieve Goossens, Geert Maleux, D Collen, Marguerite Stas	12
16	Occlusion in totally implantable vascular access devices: what is its incidence and what actions do nurses take to restore patency? 2005 ·European Journal of Cancer Supplements ·Godelieve Goossens, (unknown), (unknown), Walter Sermeus, Kathelijne Peerlinck, Marguerite Stas	1
17	Expression of the endothelin-B receptor in pigment cell lesions of the skin 2001 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Anouk Demunter, Chris De Wolf‐Peeters, H. Degreef, Marguerite Stas, Joost J. van den Oord	93
18	Clinical relevance of whole body FDG-PET (WB-PET) in recurrent malignant melanoma 1999 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marguerite Stas, Sigrid Stroobants, Patrick Dupont, (unknown), L. Van Hoe, Sandra Mulier, Maria Garmyn, Ivo De Wever, Luc Mortelmans	1
19	Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma 1998 ·Cancer Genetics and Cytogenetics ·Paola Dal Cin, Marguerite Stas, Raf Sciot, Ivo De Wever, Boudewijn Van Damme, Herman Van den Berghe	23
20	Prognostic significance of nm23-protein expression in malignant melanoma 1997 ·Melanoma Research ·Joost van den Oord, Alex Maes, Marguerite Stas, Johan Nuyts, Ivo De Wever, C. De Wolf‐Peeters	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact